USPTO serial 79378815
BOND PRIME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 26, 2026
- Examiner
- LAWRENCE, SUSAN KASTRINER
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BOND PRIME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ALEXIS P. GRILLI
ALEXIS P. GRILLI NIXON PEABODY LLP799 9TH STREET, NW, SUITE 500WASHINGTON, DC 20001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical and veterinary preparations namely reagents for medical and diagnostic purposes reagents for veterinary purposes; diagnostic preparation for medical use; antibody reagents used for the detection of antigens in cells and tissue for medical purposes; chemical reagents and diagnostic preparations for medical and veterinary purposes; medical diagnostic reagents; clinical medical reagents; medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridisation detection; diagnostic preparations in the nature of in situ-hybridisation probes for medical and veterinary purposes; diagnostic preparations in the nature of epitope retrieval solutions; enzymes and enzyme preparations for medical and diagnostic purposes; diagnostic preparations in the nature of diagnostic histological dye and stain solutions for medical purposes; dewaxing and wash buffers used with the aforementioned preparations for use in disease testing; diagnostic preparations for clinical or medical laboratory use | ACTIVE | — |
| 009 | diagnostic apparatus and instruments, not for medical purposes, for staining and visualisation of tissue or cell based samples for research and scientific use; laboratory apparatus for detection of tissue and/or cell based samples not for medical purposes; recorded and downloadable software for identifying and diagnosing cancer and other diseases and processing digital images; analysis apparatus for laboratory use for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining apparatus not for medical purposes; diagnostic measuring apparatus used to identify and/or diagnose cancer and other diseases, not for medical use; diagnostic laboratory testing apparatus incorporating chemical reagents for analysing the results of tissues and cell based samples, not for medical use | ACTIVE | — |
| 010 | Diagnostic apparatus and instruments for medical use for staining and/or visualization of tissue or cell based samples for diagnostic or medical use for pathology purposes, pathological assessment, pathological testing, or performing immunohistochemistry and in situ-hybridisation staining reactions, and histological and pathological staining; diagnostic apparatus for detection of tissue and/or cell based samples, all for medical purposes for pathology purposes, pathological assessment, pathological testing, or performing immunohistochemistry and in situ-hybridisation staining reactions, and histological and pathological staining; medical analysis and medical measuring apparatus, namely medical diagnostic instruments for the analysis of body fluids and tissue for medical diagnostic uses; medical apparatus and instruments for pathology purposes, namely, for pathological assessment, pathological testing, or performing immunohistochemistry and in situ-hybridisation staining reactions, and histological and pathological staining; apparatus for use in medical analysis, namely, medical diagnostic apparatus for pathology purposes, pathological assessment, pathological testing, or performing immunohistochemistry and in situ-hybridisation staining reactions, and histological and pathological staining; testing apparatus for medical purposes, namely, histopathology instruments, haematology instruments, both for clinical purposes, for pathology purposes, pathological assessment, pathological testing, or performing immunohistochemistry and in situ-hybridisation staining reactions, and histological and pathological staining; diagnostic medical apparatus namely, histopathology instruments, haematology instruments, both for clinical purposes, for pathology purposes, pathological assessment, pathological testing, or performing immunohistochemistry and in situ-hybridisation staining reactions, and histological and pathological staining, for promoting and controlling reaction on microarrays or under slide covertiles; in-vitro diagnostic testing apparatus incorporating chemical reagents for medical use; medical specimen collection slides for specimen collection in surgery | ACTIVE | — |
| 042 | Medical research; installation and integration of software, including within existing hospital and laboratory infrastructure; maintenance, servicing, updating and upgrading of software; all the aforementioned for use in connection with medical analysis, diagnosis and research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Leica Biosystems Melbourne Pty Ltd
- Other trademarks owned by Leica Biosystems Melbourne Pty Ltd
- Other trademarks owned by Leica Biosystems Melbourne Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named BOND PRIME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 26, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 28, 2026 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 26, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 26, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 26, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 26, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 7, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 7, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 16, 2026 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 16, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 16, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 16, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 16, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 16, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 4, 2026 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Mar 4, 2026 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Mar 4, 2026 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Mar 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 5, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 5, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 5, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 4, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 4, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 1, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 1, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 28, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2025 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Feb 12, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 12, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 19, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 15, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |